Abstract
A 91-year-old woman underwent transcatheter aortic valve replacement (TAVR) due to severe aortic stenosis (23-mm Sapien 3, Edwards Lifesciences, Irvine, California). She was on apixaban (2.5 mg twice daily) as an antithrombotic therapy due to atrial fibrillation. She was admitted to our hospital
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
